Medigen Biotechnology Corp (3176)-医療機器分野:企業M&A・提携分析

◆英語タイトル:Medigen Biotechnology Corp (3176) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011108
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月21日
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:台湾
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Medigen Biotechnology Corp (MBC) is a pharmaceutical company that carries out the research and development of biopharmaceuticals for the treatment of liver diseases and cancers. It focuses at developing new therapeutics, principally in the area of cancer and liver diseases. The company’s product portfolio includes monoclonal antibodies; vaccines; molecular diagnostics and generic drugs. MBC also provides original equipment manufacturing (OEM) and original design manufacturing (ODM) manufacturing services in various dosage forms including orals, externals, ophthalmic and hormones; nutrition supplements; cosmeceutical products. ’s subsidiaries include Medigen Vaccine Biologics; TBG Biotechnology Corp.; and Winston Medical Supply Co., Ltd. MBC is headquartered in Taipei city, Taiwan.

Medigen Biotechnology Corp (3176) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Medigen Biotechnology Corp, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Medigen Biotechnology Corp, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Medigen Biotechnology Corp, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Medigen Biotechnology Corp, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Medigen Biotechnology Corp, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Medigen Biotechnology Corp, Medical Equipment, Deal Details 10
Asset Purchase 10
Medigen Biotech Acquires B-cell Immortalization Platform Technology 10
Partnerships 11
TBG Diagnostics and Medigen Enter into Licensing Agreement with National Taiwan University Hospital 11
Equity Offering 12
Medigen Biotech Completes Public Offering Of Shares For US$4 Million 12
Medigen Biotech Completes Rights Offering Of Shares For US$32 Million 13
Medigen Biotech Announces Rights Offering Of Shares For US$21 Million 14
Medigen Biotech Announces Public Offering Of Shares For US$2.7 Million 15
Medigen Biotech Prices Public Offering Of Common Stock For US$10 Million 16
Acquisition 17
PerkinElmer Acquires Shanghai Haoyuan Biotech From Medigen Biotech For US$38 Million 17
Medigen Biotech Acquires Remaining Stake In Texas BioGene 19
Medigen Biotechnology Corp – Key Competitors 20
Medigen Biotechnology Corp – Key Employees 21
Medigen Biotechnology Corp – Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Recent Developments 23
Strategy And Business Planning 23
Nov 23, 2016: Medigen Vaccine Biologics’s Inaugurates Taiwan’s First Cell-Based Vaccine Manufacturing Plant 23
Corporate Communications 24
Jan 22, 2016: MVC was granted National Innovation Award for the application of cell-based production technologies in mock-up vaccine manufacturing 24
Appendix 25
Methodology 25
About GlobalData 25
Contact Us 25
Disclaimer 25

List of Tables
Medigen Biotechnology Corp, Medical Equipment, Key Facts, 2015 2
Medigen Biotechnology Corp, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Medigen Biotechnology Corp, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Medigen Biotechnology Corp, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Medigen Biotechnology Corp, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Medigen Biotechnology Corp, Deals By Market, 2011 to YTD 2017 8
Medigen Biotechnology Corp, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Medigen Biotech Acquires B-cell Immortalization Platform Technology 10
TBG Diagnostics and Medigen Enter into Licensing Agreement with National Taiwan University Hospital 11
Medigen Biotech Completes Public Offering Of Shares For US$4 Million 12
Medigen Biotech Completes Rights Offering Of Shares For US$32 Million 13
Medigen Biotech Announces Rights Offering Of Shares For US$21 Million 14
Medigen Biotech Announces Public Offering Of Shares For US$2.7 Million 15
Medigen Biotech Prices Public Offering Of Common Stock For US$10 Million 16
PerkinElmer Acquires Shanghai Haoyuan Biotech From Medigen Biotech For US$38 Million 17
Medigen Biotech Acquires Remaining Stake In Texas BioGene 19
Medigen Biotechnology Corp, Key Competitors 20
Medigen Biotechnology Corp, Key Employees 21
Medigen Biotechnology Corp, Other Locations 22
Medigen Biotechnology Corp, Subsidiaries 22

★海外企業調査レポート[Medigen Biotechnology Corp (3176)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Carlsberg A/S:企業の戦略・SWOT・財務情報
    Carlsberg A/S - Strategy, SWOT and Corporate Finance Report Summary Carlsberg A/S - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • APRIL Group S.A. (APR):企業の財務・戦略的SWOT分析
    APRIL Group S.A. (APR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Human Longevity Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Human Longevity Inc (HLI) is a genomics-based technology company that develops sequenced genomes and phenotypic database. The company’s discovery capabilities include streamlining drug development, rescuing and repurposing drugs from failed clinical trials and discovery of biomarker and comp …
  • Mitsui Fudosan Co., Ltd.:企業の戦略・SWOT・財務情報
    Mitsui Fudosan Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Mitsui Fudosan Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Equinor ASA (EQNR):電力:M&Aディール及び事業提携情報
    Summary Equinor ASA (Equinor), formerly Statoil ASA, is an energy company. It focuses mainly on the exploration, development and production of crude oil and natural gas on the Norwegian Continental Shelf (NCS). The company also has operations in several of the important oil and gas provinces in the …
  • Henry Ford Health System:企業の戦略的SWOT分析
    Henry Ford Health System - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Intellect Design Arena Limited:企業の戦略・SWOT・財務分析
    Intellect Design Arena Limited - Strategy, SWOT and Corporate Finance Report Summary Intellect Design Arena Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Cardiovascular Systems Inc (CSII):企業の財務・戦略的SWOT分析
    Summary Cardiovascular Systems Inc (CSI) is a medical device company that develops and commercializes products for the treatment of peripheral and coronary vascular disease. The company's products include peripheral orbital atherectomy system, coronary orbital atherectomy system, crowns, and accesso …
  • Cerus Energy Group Ltd (CEA):企業の財務・戦略的SWOT分析
    Summary Cerus Energy Group Ltd (Cerus Energy), formerly Petrostar Petroleum Corp is an oil and gas company that produces methanol, DME, and petroleum and natural gas. The company offers deep well disposal, storage and terminalling services, and well management services. Its well management services …
  • Kimbell Royalty Partners LP (KRP):石油・ガス:M&Aディール及び事業提携情報
    Summary Kimbell Royalty Partners LP (KRP), is an oil and gas company that owns and acquires mineral and royalty interests in oil and natural gas properties throughout the US. The company has interests in the Permian Basin, Eagle Ford, Bakken Shale, San Juan Basin, Mid-Continent, East Texas, Barnett …
  • SerComm Corp (5388):企業の財務・戦略的SWOT分析
    SerComm Corp (5388) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Kwality Group:企業の戦略・SWOT・財務分析
    Kwality Group - Strategy, SWOT and Corporate Finance Report Summary Kwality Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • International Flavors & Fragrances Inc.:戦略・SWOT・企業財務分析
    International Flavors & Fragrances Inc. - Strategy, SWOT and Corporate Finance Report Summary International Flavors & Fragrances Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • Falck Renewables S.p.A. (FKR):企業の財務・戦略的SWOT分析
    Falck Renewables S.p.A. (FKR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Ascent Solar Technologies Inc (ASTI):企業の財務・戦略的SWOT分析
    Ascent Solar Technologies Inc (ASTI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Apricus Biosciences Inc (APRI):製薬・医療:M&Aディール及び事業提携情報
    Summary Apricus Biosciences Inc (Apricus) develops and commercializes pharmaceutical products indicated for the treatment of various therapeutic classes including urology and rheumatology. Its product pipeline includes, Vitaros (alprostadil), a topical vasodilator cream in-licensed from Warner Chilc …
  • BioInvent International AB (BINV):企業の財務・戦略的SWOT分析
    BioInvent International AB (BINV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Can-Fite BioPharma Ltd (CANF):企業の財務・戦略的SWOT分析
    Summary Can-Fite BioPharma Ltd (Can-Fite) is a clinical stage drug development Company that strives to develop small molecule drugs for the treatment of cancer and inflammatory diseases. The company’s pipeline products which are in phase II and III clinical development stage includes CF101, for rheu …
  • Verisante Technology Inc (VRS):製品パイプライン分析
    Summary Verisante Technology Inc (Verisante), develops and commercializes products for the early detection of all forms of skin cancer. The company’s key product offerings include Verisante Aura, Verisante Core and Verisante MSI Camera. The Verisante Aura is used for skin cancer detection, and Veris …
  • Baltimore Gas and Electric Company:発電所・企業SWOT分析
    Baltimore Gas and Electric Company - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information o …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆